|
26.12.2024 14:10:40
|
Why Hoth Therapeutics Is Rising In Pre-market?
(RTTNews) - Hoth Therapeutics (HOTH) has entered into an exclusive patent license agreement with the U.S. Department of Veterans Affairs, providing the company with exclusive rights to a jointly owned patent portfolio co-developed by the the U.S. Department of Veterans Affairs and Emory University. The licensed technology centers on Glial Cell Line-Derived Neurotrophic Factor, Obesity, and Obesity-Related Diseases and Conditions. Hoth Therapeutics will have exclusive rights to develop, market, and commercialize products and processes derived from the licensed patents.
Hoth has also entered into an agreement to protect its intellectual property by signing an LOI to acquire additional provisional patent protection for its therapeutic HT-001.
Shares of Hoth Therapeutics are up 9% in pre-market trade on Thursday.
For More Such Health News, visit rttnews.com.
Analysen zu Hoth Therapeutics Inc Registered Shs
Im BX Morningcall werden folgende Aktien analysiert und erklärt:
✅ LPL Finance
✅ Blackstone
✅ Ares Management
👉🏽 https://bxplus.ch/bx-musterportfolio/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
US-Börsen im Rückwärtsmodus -- SMI geht im Plus ins Wochenende -- DAX schliesst nach Rekordhoch über 21'500-Punkte-Marke etwas tiefer -- Hang Seng legt letztlich kräftig zuDer heimische Aktienmarkt zeigte sich am Freitag etwas höher, während der deutsche Leitindex nach neuen Rekorden ins Minus drehte. Die US-Börsen notierten schwächer. Die asiatischen Indizes zeigten sich zum Wochenausklang überwiegend freundlich.
finanzen.net News
| Datum | Titel |
|---|---|
|
{{ARTIKEL.NEWS.HEAD.DATUM | date : "HH:mm" }}
|
{{ARTIKEL.NEWS.BODY.TITEL}} |